Atara Biotherapeutics, Inc. (ATRA) vs Pulmonx Corporation (LUNG)
A side-by-side comparison of Atara Biotherapeutics, Inc. and Pulmonx Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRA
Atara Biotherapeutics, Inc.
$9.28HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
LUNG
Pulmonx Corporation
$1.83HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — ATRA vs LUNG
growth of $100 · dividends reinvested · last 6yATRA -97.2% (-44.8%/yr)LUNG -95.2% (-39.8%/yr)LUNG compounded faster over this window
ATRA LUNG
ATRA vs LUNG: by the numbers
- •ATRA is the larger company ($84M vs $77M market cap).
- •Both run net losses; LUNG's is the smaller (-55.03% vs -269.42% net margin).
- •ATRA grew revenue faster over the past five years (56.10% vs 15.86% CAGR).
Metrics side by side
Valuation
| Metric | ATRA | LUNG |
|---|---|---|
| P/S ratio | 13.50 | 0.89 |
| P/B ratio | N/A | 1.98 |
Profitability
| Metric | ATRA | LUNG |
|---|---|---|
| Gross margin | 82.44% | 77.06% |
| Operating margin | 29.69% | -52.96% |
| Net margin | -269.42% | -55.03% |
| ROE | N/A | -122.76% |
| ROIC | -100.35% | -48.39% |
Growth (annualized)
| Metric | ATRA | LUNG |
|---|---|---|
| Revenue CAGR (5Y) | 56.10% | 15.86% |
| Total return CAGR (5Y) | -53.60% | -45.30% |
Frequently asked
- Which has grown faster, ATRA or LUNG?
- Over the past five years, ATRA grew revenue faster — ATRA at a 56.10% CAGR versus LUNG at 15.86%.
- How have ATRA and LUNG total returns compared?
- Over the past 5 years, ATRA delivered -53.60% and LUNG delivered -45.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Atara Biotherapeutics ROEPulmonx ROEAtara Biotherapeutics operating marginPulmonx operating marginAtara Biotherapeutics revenue growthPulmonx revenue growthAtara Biotherapeutics free cash flowPulmonx free cash flow
Atara Biotherapeutics & Pulmonx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.